CNS Disorders  >>  ponezumab (PF-04360365)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ponezumab (PF-04360365) / Pfizer
NCT00945672 / 2009-011172-30: A Multiple Dose Study of PF-04360365 In Patients With Mild to Moderate Alzheimer's Disease

Completed
2
36
Europe
PF-04360365 10 mg/kg, PF-04360365 7.5 mg/kg, placebo
Pfizer
Alzheimer's Disease
06/11
06/11
NCT00722046 / 2008-000986-42: Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease

Completed
2
198
Europe, Canada, US, RoW
PF-04360365 0.1 mg/kg, PF-04360365 0.5 mg/kg, PF-04360365 1 mg/kg, Placebo, PF-04360365 3 mg/kg, PF-04360365 8.5 mg/kg
Pfizer
Alzheimer's Disease
08/11
08/11

Download Options